Mereo BioPharma MREO
NASDAQ MREO
$0.31 +0.01 (+2.92%)
At close: Nov 11, 2026 · 4:00 PM EST

Mereo BioPharma (MREO) Gross Margin (2023 - 2026)

Updated

Mereo BioPharma's Gross Margin came in at 73.40% for FY2025.

Analysis

Mereo BioPharma (MREO) Gross Margin (2023 - 2026) Analysis & Trends

  • Gross Margin carries a four-year change of +22.51 percentage points (FY2021 to FY2025).
  • The FY2025 figure represents the lowest annual Gross Margin since FY2021.
  • Per Business Quant, earlier years put Gross Margin at 74.26% in FY2023 and 50.89% in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 83.88%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 68.12%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 75.38%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 72.95%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 88.03%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 73.10%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 81.07%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 75.71%
10 Mereo BioPharma 47.91 Mn -79.40 Mn 800,000.00 100.00%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 100.00%
Jun 30, 2025 73.60%
Dec 31, 2023 127.30%
Jun 30, 2023 61.89%
API Access

Mereo BioPharma Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=MREO&period=max&api_key=YOUR_API_KEY